Identification of novel CAR T cell brain cancer targets using high throughput synthetic biology omics assays

• Masters by Coursework
• Honours

Glioblastoma is an aggressive form of brain cancer with limited effective treatment options. Chimeric Antigen Receptor (CAR) T cell therapy, an emerging field involving the engineering of immune cells, holds great potential for the treatment of glioblastoma.

This project will aim to identify novel CAR T cell therapies by applying synthetic biology principles through the use of protein display assays. This project offers an opportunity for students with an interest in synthetic biology, oncology, protein engineering, and genomics to contribute to a significant area of cancer research.